Amgen director granted 665 RSUs in stock award

Amgen Inc. director Wanda M. Austin received a stock-based compensation award.

Rhea-AI Filing Summary

Amgen Inc. director Wanda M. Austin received a stock-based compensation award. She acquired 665 shares of Amgen common stock on May 19, 2026 through a grant classified as a “grant, award, or other acquisition,” not an open-market purchase.

The shares came from Restricted Stock Units granted under Amgen’s 2009 Director Incentive Program within the company’s equity incentive plan. According to the footnote, these RSUs vested immediately and are paid in common stock on a one-to-one basis, with an option for the director to defer receipt. Following this grant, Austin directly holds 8,018 shares of Amgen common stock.

Insider Trade Summary

Grant/Award: 665 shares

Grant/Award 1 txn

Insider Austin Wanda M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	665	$0.00	$0.00

Holdings After Transaction: Common Stock — 8,018 shares (Direct)

Footnotes (1)

1. F1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.

Key Figures

Shares granted: 665 shares Post-transaction holdings: 8,018 shares Grant transaction price: $0.0000 per share +2 more

5 metrics

Shares granted 665 shares Restricted Stock Units converted to common stock on May 19, 2026

Post-transaction holdings 8,018 shares Common stock directly held by Wanda M. Austin after grant

Grant transaction price $0.0000 per share Reported transaction price for the RSU share issuance

Transaction code A Grant, award, or other acquisition of non-derivative common stock

Transaction direction acquire Non-derivative acquisition via stock-based compensation grant

Key Terms

Restricted Stock Units (RSUs), Amgen Inc. 2009 Director Incentive Program, Second Amended and Restated 2009 Equity Incentive Plan, Form 4, +1 more

5 terms

Restricted Stock Units (RSUs) financial

"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program..."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Amgen Inc. 2009 Director Incentive Program financial

"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended..."

Second Amended and Restated 2009 Equity Incentive Plan financial

"...under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Amgen (AMGN) director Wanda M. Austin report on this Form 4?

Amgen director Wanda M. Austin reported receiving 665 shares of common stock as a stock-based compensation grant. The award reflects Restricted Stock Units that vested immediately and were paid in shares, increasing her direct holdings to 8,018 shares after the transaction.

Was Wanda M. Austin’s Amgen (AMGN) transaction an open-market stock purchase?

No. The filing shows a Form 4 code A transaction, described as a grant, award, or other acquisition. The 665 shares came from vested Restricted Stock Units granted under Amgen’s director incentive program, not from buying shares in the open market.

How many Amgen (AMGN) shares does Wanda M. Austin hold after this grant?

After the award of 665 shares, Wanda M. Austin directly holds 8,018 shares of Amgen common stock. This total reflects her position immediately following the vesting and settlement of the Restricted Stock Units described in the Form 4 filing.

What plan governed the Restricted Stock Units granted to Amgen (AMGN) director Wanda M. Austin?

The Restricted Stock Units were granted under the Amgen Inc. 2009 Director Incentive Program, as amended, within the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan. These plan documents govern award terms, vesting, and settlement mechanics for the director’s RSUs.

Did the Restricted Stock Units in this Amgen (AMGN) Form 4 vest immediately?

Yes. The footnote states that the Restricted Stock Units granted to Wanda M. Austin vested immediately. Once vested, the RSUs are paid in shares of Amgen common stock on a one-to-one basis, with an option for the director to defer the payment schedule.

Can Wanda M. Austin defer receipt of shares from her Amgen (AMGN) RSUs?

Yes. The footnote explains that vested Restricted Stock Units may be deferred by the director. If deferred, payment of the vested RSUs in Amgen common stock will occur according to the deferral schedule elected under the applicable program rules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 06:54 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Austin Wanda M

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		665	A	$0	8,018(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.

	/s/ Wanda M. Austin	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)